11C-Acetate PET/CT Monitoring Therapy of Multiple Myeloma. (July 2016)

• Record Type: Journal Article
• Authors: Zhu, Wenjia; Dang, Yonghong; Ma, Yanru; Li, Fang; Huo, Li
• Is Part Of: Clinical nuclear medicine. Volume 41:Number 7(2016)
• Publication Date: 2016-07
• Subjects: 11C-acetate -- FDG -- multiple myeloma -- PET/CT -- skeletal system; Nuclear medicine -- Periodicals; Radioisotope scanning -- Periodicals; Nuclear Medicine -- Periodicals; 616.07575
• DOI: 10.1097/RLU.0000000000001215
• Languages: English
• ISSNs: 0363-9762

Abstract

Abstract : Abstract: A 67-year-old man with newly diagnosed multiple myeloma underwent both FDG and 11 C-acetate PET/CT sequentially on different days. There was increased FDG activity only in L1 vertebral body, but there was diffuse abnormal 11 C-acetate activity throughout the skeletal system. After the successful therapy, the patient who was on remission clinically underwent follow-up PET/CT scans. Interestingly, L1 remained to have elevated FDG, although with less intensity. In contrast, there was no abnormal 11 C-acetate activity anywhere in the body. The patient remained in remission clinically.